picropodophyllin has been researched along with Elephantiasis Neuromatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalasani, A; Kraniak, JM; Mattingly, RR; Wallace, MR | 1 |
1 other study(ies) available for picropodophyllin and Elephantiasis Neuromatosis
| Article | Year |
|---|---|
Development of 3D culture models of plexiform neurofibroma and initial application for phenotypic characterization and drug screening.
Topics: Antineoplastic Agents; Benzimidazoles; Bone Morphogenetic Protein 2; Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Genes, Neurofibromatosis 1; Genes, Reporter; Humans; Luminescent Proteins; MAP Kinase Kinase 1; Molecular Targeted Therapy; Neurofibroma, Plexiform; Neurofibromatosis 1; Phenotype; Podophyllotoxin; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptor, IGF Type 1; Red Fluorescent Protein; Schwann Cells; Transduction, Genetic; Tumor Cells, Cultured | 2018 |